Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
PLoS One. 2013 Aug 14;8(8):e70814. doi: 10.1371/journal.pone.0070814. eCollection 2013.
Understanding the genetic, antigenic and structural changes that occur during HIV-1 infection in response to pre-existing immunity will facilitate current efforts to develop an HIV-1 vaccine. Much is known about HIV-1 variation at the population level but little with regard to specific changes occurring in the envelope glycoprotein within a host in response to immune pressure elicited by antibodies. The aim of this study was to track and map specific early genetic changes occurring in the viral envelope gene following vaccination using a highly controlled viral challenge setting in the SHIV macaque model. We generated 449 full-length env sequences from vaccinees, and 63 from the virus inoculum. Analysis revealed a different pattern in the distribution and frequency of mutations in the regions of the envelope gene targeted by the vaccine as well as different patterns of diversification between animals in the naïve control group and vaccinees. Given the high stringency of the model it is remarkable that we were able to identify genetic changes associated with the vaccination. This work provides insight into the characterization of breakthrough viral populations in less than fully efficacious vaccines and illustrates the value of HIV-1 Env SHIV challenge model in macaques to unravel the mechanisms driving HIV-1 envelope genetic diversity in the presence of vaccine induced-responses.
了解 HIV-1 感染过程中针对预先存在的免疫反应而发生的遗传、抗原和结构变化,将有助于目前开发 HIV-1 疫苗的努力。人们对 HIV-1 在人群水平上的变异有很多了解,但对宿主中包膜糖蛋白在抗体引起的免疫压力下发生的特定变化知之甚少。本研究旨在使用 SHIV 猕猴模型中的高度受控病毒挑战设置,跟踪和绘制接种疫苗后病毒包膜基因中特定的早期遗传变化,并对其进行定位。我们从疫苗接种者中生成了 449 个全长 env 序列,从病毒接种物中生成了 63 个。分析显示,疫苗靶向的包膜基因区域的突变分布和频率存在不同模式,以及未接种组和疫苗接种组动物之间的多样化模式也不同。鉴于该模型的高度严格性,令人惊讶的是,我们能够确定与接种相关的遗传变化。这项工作深入了解了在不完全有效的疫苗中突破病毒群体的特征,并说明了在存在疫苗诱导反应的情况下,使用 HIV-1 Env SHIV 挑战模型在猕猴中阐明驱动 HIV-1 包膜遗传多样性的机制的价值。